|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2000-5-18
|
|
pubmed:abstractText |
To determine whether [(18)F]-fluorodeoxy-D-glucose ([(18)F]-FDG) positron emission tomography (PET) can predict the pathologic response of primary and metastatic breast cancer to chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:Ah-SeeA KAK,
pubmed-author:ChilcoteWW,
pubmed-author:EreminOO,
pubmed-author:GilbertF JFJ,
pubmed-author:HeysS DSD,
pubmed-author:HutcheonA WAW,
pubmed-author:MillerI DID,
pubmed-author:PayneSS,
pubmed-author:SharpP FPF,
pubmed-author:SmithI CIC,
pubmed-author:WaikarSS,
pubmed-author:WelchA EAE,
pubmed-author:WhitakerTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1676-88
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10764428-Adult,
pubmed-meshheading:10764428-Aged,
pubmed-meshheading:10764428-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10764428-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10764428-Axilla,
pubmed-meshheading:10764428-Biopsy,
pubmed-meshheading:10764428-Breast Neoplasms,
pubmed-meshheading:10764428-Cyclophosphamide,
pubmed-meshheading:10764428-Doxorubicin,
pubmed-meshheading:10764428-Female,
pubmed-meshheading:10764428-Fluorodeoxyglucose F18,
pubmed-meshheading:10764428-Humans,
pubmed-meshheading:10764428-Lymph Nodes,
pubmed-meshheading:10764428-Lymphatic Metastasis,
pubmed-meshheading:10764428-Middle Aged,
pubmed-meshheading:10764428-Paclitaxel,
pubmed-meshheading:10764428-Prednisolone,
pubmed-meshheading:10764428-Radiopharmaceuticals,
pubmed-meshheading:10764428-Sensitivity and Specificity,
pubmed-meshheading:10764428-Taxoids,
pubmed-meshheading:10764428-Tomography, Emission-Computed,
pubmed-meshheading:10764428-Vincristine
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
|
|
pubmed:affiliation |
John Mallard Scottish Positron Emission Tomography Center, Scotland, United Kingdom. i.c.smith@abdn.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
